RecruitingNCT03794466

Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization

Quantification of Pain Relief With Gonadal Vein Embolization for Pelvic Congestion Syndrome


Sponsor

University of Kansas Medical Center

Enrollment

30 participants

Start Date

May 10, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment, or poor response to treatment.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria3

  • Female patients 18 years of age or older
  • Meet the clinical and imaging criteria for the diagnosis of PCS and have no contraindications to coil embolization of the gonadal veins.
  • Patients who are treated with coil embolization of the gonadal veins in the Interventional Radiology division between October 1, 2018 to October 1, 2019.

Exclusion Criteria3

  • Patients less than 18 years of age.
  • Patients who are found to have an underlying cause of pelvic congestion syndrome unrelated to venous congestion and insufficiency. This includes, but is not limited to, nutcracker syndrome, or a mass resulting in extrinsic compression of the gonadal veins.
  • Patients who have received prior surgical therapy for PCS, including bilateral salpingo-oophorectomy (TAH-BSO), gonadal vein resection, or gonadal vein ligation.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The University of Kansas Medical Center

Kansas City, Kansas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03794466


Related Trials